Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions

Written by Regenerative Medicine

Open Access Research Article article by Suzanne Farid, Sally Hassan, Ana S Simaria et al. (University College London, UK, and Lonza Walkersville, Inc., Walkersville, MD, USA) on the development of a tool to identify the most cost-effective methods for allogenic cell therapies. Allogenic stem cell therapies have demonstrated the potential to help treat many different diseases or disorders, such as osteoarthritis. However, these products often experience difficulties in scale-up for large-scale manufacturing, meaning there is a need to better estimate manufacturing costs and identify opportunities to reduce costs. This Open Access Research Article by Sally Hassan, Ana S Simaria, Hemanthram...

To view the full article, please register now for access

It's completely free